Position in ABBV
as of Jun 30, 2026
· filed Aug 7, 2026
Position Value
$458,236
-$207,935 QoQ
Shares Held
1,821
-40.5% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.57%
of 13F equity value
Holder Rank
#3,248
of 4,150 holders
Holding Since
Jun 2023
7 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Kingdom Financial Group LLC. holds $1,463,105 across 13 Drug Manufacturers - General names. ABBV ranks #1 (31.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
This page
|
1,821 | $458,236 | |
| 2 | AMGN |
Amgen Inc
|
879 | $318,303 | |
| 3 | GILD |
Gilead Sciences, Inc.
|
2,247 | $283,885 | |
| 4 | JNJ |
Johnson & Johnson
|
1,027 | $260,827 | |
| 5 | NVO |
Novo Nordisk A S
|
1,374 | $65,869 | |
| 6 | MRK |
Merck & Co., Inc.
|
211 | $27,113 | |
| 7 | LLY |
ELI LILLY & Co
|
22 | $26,387 | |
| 8 | PFE |
Pfizer Inc
|
587 | $14,134 |
All Filings in ABBV
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $458,236 | 1,821 | Shares | Sole | 2026-08-07 | |
| 2026-03-31 | $666,171 | 3,063 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $684,099 | 2,994 | Shares | Sole | 2026-02-06 | |
| 2025-09-30 | $208,849 | 902 | Shares | Sole | 2025-10-30 | |
| 2023-12-31 | $255,390 | 1,648 | Shares | Sole | 2024-01-17 | |
| 2023-09-30 | $351,334 | 2,357 | Shares | Sole | 2023-10-16 | |
| 2023-06-30 | $240,897 | 1,788 | Shares | Sole | 2023-07-31 | |
| No filing history on record for this holder in this stock. | ||||||